Loading...
XNAS
IDXX
Market cap57bUSD
Dec 04, Last price  
717.47USD
1D
-1.17%
1Q
11.58%
Jan 2017
511.81%
Name

IDEXX Laboratories Inc

Chart & Performance

D1W1MN
XNAS:IDXX chart
P/E
64.53
P/S
14.70
EPS
11.12
Div Yield, %
Shrs. gr., 5y
-1.00%
Rev. gr., 5y
10.12%
Revenues
3.90b
+6.46%
638,095,000739,117,000922,555,0001,024,030,0001,031,633,0001,103,392,0001,218,689,0001,293,338,0001,377,058,0001,485,807,0001,601,892,0001,775,423,0001,969,058,0002,213,242,0002,406,908,0002,706,655,0003,215,360,0003,367,324,0003,660,953,0003,897,504,000
Net income
888m
+5.07%
78,254,00093,678,00094,014,000116,169,000122,225,000141,284,000161,786,000178,267,000187,800,000181,906,000192,078,000222,045,000263,144,000377,031,000427,720,000581,776,000744,845,000679,089,000845,042,000887,867,000
CFO
929m
+2.48%
116,552,000109,826,000135,124,000143,343,000173,718,000178,833,000220,700,000230,282,000245,996,000235,846,000216,364,000334,571,000373,276,000400,084,000459,158,000648,063,000755,546,000542,984,000906,510,000929,001,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers and SARS-CoV-2 RT-PCR that are used in the human point-of-care medical diagnostics market; in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers; SNAP rapid assays test kits. In addition, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
IPO date
Jun 21, 1991
Employees
11,000
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT